Bad Blankenburg. Intercus GmbH retained I-ADVISE AG to assess options to fund its strategic growth perspectives. Such growth financing was provided by the new minority shareholder bm|t beteiligungsmanagement thüringen gmbh, Erfurt.
The cash injected into equity will support Intercus in its efforts to develop marketable product innovations and to expand into new regional markets.
„bm|t and Intercus form a partnership that is built on a long-term relationship and reliability. Intercus is therefore ready to cope with coming challenges and well-prepared to take advantage of new opportunities”, explained Thomas Busch, managing director of Intercus.
Since 15 years Intercus develops and manufactures implants in the field of traumatology and orthopaedy for domestic and international markets. Intercus specialises on polyaxial locking systems and innovative products enhancing wound healing.
Together with well-renowned clinics and universities from all over the world, Intercus’ R&D department seeks to develop new implants and to identify new materials. Intercus’ highest quality products are manufactured in a state-of-the-art production site in Thuringia.
Back in 2003, bm|t was founded by its sole shareholder Thuringia development bank (“Thüringer Aufbaubank”). Its funds are used to provide equity capital to younger and also well-established enterprises from Thuringia with particular growth perspectives. In general, equity financing is provided by Midcap Fund for Thuringia (“Mittelstands-Fonds Thüringen”) which is managed by bm|t.